We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Non-Invasive Electroceuticals Offer Drug-Free Pain Relief

By HospiMedica International staff writers
Posted on 16 Nov 2020
A pulsed shortwave therapy (PSWT) device treats any form of musculoskeletal pain, increases physical functionality, and improves overall quality of life.

The BioElectronics (Frederick, MD, USA) ActiPatch treats various types of pain via diathermal electromagnetic energy delivered by repeated application of a PSWT signal at intensity levels too low to trigger a pain response. More...
The signal can, however, still initiate a neural system response, as it is not only exposed to the applied signal, but also to background physiologic signals, which enhances the detection of sub-threshold stimuli. The PSWT signal is delivered at a frequency of 27.12 MHz and pulses of 1,000 times per second, which each pulse sustained for a duration of 100 μs.

The prolonged stochastic stimuli, which the brain cannot really interpret, are sufficiently large to exceed the threshold necessary to activate nerves. Since sensory nerves have a lower threshold of activation as compared to motor nerves and muscles, the low incident power is sufficient to non-deterministically modulate their activity. And as the signal is lower than the stochastic resonance threshold, the patient experiences no heat, nor any other abnormal or unpleasant sensation. The PSWT localized treatment can be used as either a standalone or adjunct therapy, depending on the condition being treated.

“Electroceutical devices can target central sensitization and are ideal for treating pain, but existing options, such as transcutaneous electrical nerve stimulation, require invasive or semi-invasive use and produce uncomfortable sensations,” said the company in a press statement. “ActiPatch reduces chronic pain by mitigating nerve hypersensitivity associated with central sensitization. This means that our products can be further developed to treat disorders beyond pain such as overactive bladder.”

ActiPatch is available in three forms: a back wrap, a knee wrap, and as an adhesive which can be applied as per specifications at the site of chronic, persistent pain, such as for back pain, knee/shoulder/ankle arthritis, postoperatively after knee/spine surgeries, tendonitis, ligament injury, elbow/wrist persistent pain, plantar fasciitis, and fibromyalgia. It contains an electronics module and a wire loop that is placed around the affected area. Total usage duration is 720 hours.

Related Links:
BioElectronics


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.